JP2009530283A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530283A5
JP2009530283A5 JP2009500436A JP2009500436A JP2009530283A5 JP 2009530283 A5 JP2009530283 A5 JP 2009530283A5 JP 2009500436 A JP2009500436 A JP 2009500436A JP 2009500436 A JP2009500436 A JP 2009500436A JP 2009530283 A5 JP2009530283 A5 JP 2009530283A5
Authority
JP
Japan
Prior art keywords
composition
optionally substituted
hydrogen
aliphatic
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530283A (ja
JP5269758B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006321 external-priority patent/WO2007109024A2/en
Publication of JP2009530283A publication Critical patent/JP2009530283A/ja
Publication of JP2009530283A5 publication Critical patent/JP2009530283A5/ja
Application granted granted Critical
Publication of JP5269758B2 publication Critical patent/JP5269758B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500436A 2006-03-16 2007-03-14 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体 Expired - Fee Related JP5269758B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78289406P 2006-03-16 2006-03-16
US60/782,894 2006-03-16
PCT/US2007/006321 WO2007109024A2 (en) 2006-03-16 2007-03-14 Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013040395A Division JP2013100371A (ja) 2006-03-16 2013-03-01 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体

Publications (3)

Publication Number Publication Date
JP2009530283A JP2009530283A (ja) 2009-08-27
JP2009530283A5 true JP2009530283A5 (https=) 2011-03-17
JP5269758B2 JP5269758B2 (ja) 2013-08-21

Family

ID=38328199

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009500436A Expired - Fee Related JP5269758B2 (ja) 2006-03-16 2007-03-14 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体
JP2013040395A Pending JP2013100371A (ja) 2006-03-16 2013-03-01 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013040395A Pending JP2013100371A (ja) 2006-03-16 2013-03-01 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体

Country Status (15)

Country Link
US (4) US20090143442A1 (https=)
EP (3) EP2001468B1 (https=)
JP (2) JP5269758B2 (https=)
KR (1) KR101475955B1 (https=)
CN (1) CN101454005B (https=)
AU (1) AU2007227581B2 (https=)
CA (1) CA2646207C (https=)
ES (2) ES2654908T3 (https=)
HU (1) HUE035314T2 (https=)
MX (2) MX2008011871A (https=)
NZ (1) NZ571871A (https=)
PL (2) PL2902026T3 (https=)
RU (1) RU2445957C2 (https=)
UA (1) UA96441C2 (https=)
WO (1) WO2007109024A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA96441C2 (ru) 2006-03-16 2011-11-10 Метаболик Солюшнз Девелопмент Компани Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
CN101448500A (zh) * 2006-03-16 2009-06-03 新陈代谢解决方案开发公司 噻唑烷二酮类似物和糖皮质激素激动剂的组合疗法
WO2007109037A2 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
KR101537830B1 (ko) 2007-09-14 2015-07-17 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 고혈압 치료용 티아졸리딘디온 유사체
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
ME01898B (me) 2008-08-12 2014-12-20 Zinfandel Pharmaceuticals Inc Metoda za identifikaciju faktora rizika od alchajmerove bolesti
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
ES2617704T3 (es) * 2009-12-15 2017-06-19 Octeta Therapeutics, Llc Tiazolidindionas ahorradoras de PPAR y combinaciones para el tratamiento de enfermedades neurodegenerativas
AU2014202074B2 (en) * 2009-12-15 2016-01-07 Cirius Therapeutics, Inc. PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
RU2564661C2 (ru) 2009-12-15 2015-10-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
JP2013514369A (ja) * 2009-12-15 2013-04-25 メタボリック ソリューションズ ディベロップメント カンパニー, エルエルシー 糖尿病および他の代謝性疾患を処置するための、ppar温存チアゾリジンジオンおよび組み合わせ物
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB2477743A (en) * 2010-02-10 2011-08-17 Argenta Therapeutics Ltd Enantiomers of 5-methyl-thiazolidine-2,4-dione glitazone compounds
AU2011242955A1 (en) * 2010-04-19 2012-11-01 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
MX2012012092A (es) 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
KR101988203B1 (ko) 2010-08-10 2019-06-11 씨리우스 테라퓨틱스, 엘엘씨 티아졸리딘디온 화합물의 신규한 합성법
CA2807815C (en) * 2010-08-10 2018-10-02 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
AU2012205798B2 (en) 2011-01-10 2016-02-25 Takeda Pharmaceutical Company Limited Methods and drug products for treating Alzheimer's disease
WO2012114204A2 (en) 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
WO2012149083A1 (en) * 2011-04-28 2012-11-01 Metabolic Solutions Development Company, Llc Ppar-sparing thiazolidinediones for the treatment of kidney related diseases
KR20130015932A (ko) * 2011-08-05 2013-02-14 연세대학교 산학협력단 저용량의 치아졸리딘다이온을 포함하는 알츠하이머 병 치료용 약학조성물
KR101501375B1 (ko) 2012-09-21 2015-03-10 가톨릭대학교 산학협력단 메트포민을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 조성물
WO2014046474A2 (ko) * 2012-09-21 2014-03-27 가톨릭대학교 산학협력단 메트포민을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 조성물
EP2931274A1 (en) * 2012-12-11 2015-10-21 Metabolic Solutions Development Company LLC Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
CA2941562C (en) 2013-03-14 2021-09-21 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
WO2015013187A1 (en) 2013-07-22 2015-01-29 Metabolic Solutions Development Co., Llc Ppar-sparing compounds for the treatment of metabolic diseases
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
EP3125888B1 (en) 2014-04-02 2018-05-23 Minoryx Therapeutics S.L. 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
EP3548026B1 (en) 2016-12-01 2021-01-20 Minoryx Therapeutics S.L. 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
GB202210503D0 (en) 2022-07-18 2022-08-31 Univ Court Univ Of Glasgow Materials and methods for treatment of chronic myeloid leukemia (CML)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
WO1985004170A1 (fr) * 1984-03-21 1985-09-26 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
WO1986002073A1 (fr) 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US5167228A (en) * 1987-06-26 1992-12-01 Brigham And Women's Hospital Assessment and modification of endogenous circadian phase and amplitude
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
CA2106967C (en) * 1991-04-11 2003-12-09 Takashi Sohda Thiazolidinedione derivatives, production and use thereof
NO302471B1 (no) 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
AU679572B2 (en) * 1993-09-15 1997-07-03 Daiichi Sankyo Company, Limited Use of thiazolidinediones to prevent or delay onset of NIDDM
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5798375A (en) 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
GB0030845D0 (en) * 2000-12-18 2001-01-31 Smithkline Beecham Plc Novel treatment
US7009057B2 (en) 2001-04-26 2006-03-07 Zentiva A.S. Method for obtaining pioglitazone as an antidiabetic agent
EP1690538A4 (en) * 2003-12-02 2009-02-25 Shionogi & Co ISOXAZOLE DERIVATIVE AGONISTIC ACTION AGAINST PEROXISOM PROLIFERATOR ACTIVATED RECEPTOR
CN101448500A (zh) * 2006-03-16 2009-06-03 新陈代谢解决方案开发公司 噻唑烷二酮类似物和糖皮质激素激动剂的组合疗法
WO2007109037A2 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
UA96441C2 (ru) 2006-03-16 2011-11-10 Метаболик Солюшнз Девелопмент Компани Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
KR101537830B1 (ko) 2007-09-14 2015-07-17 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 고혈압 치료용 티아졸리딘디온 유사체

Similar Documents

Publication Publication Date Title
JP2009530283A5 (https=)
HRP20210252T1 (hr) Heterociklički amidi kao inhibitori kinaze
RU2008140943A (ru) Аналоги тиазолидиндиона
JP2010533203A5 (https=)
JP2017526711A5 (https=)
JP2012505891A5 (https=)
JP2011525192A5 (https=)
JP2013501720A5 (https=)
NZ597381A (en) Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
JP2013533314A5 (https=)
JP2009539848A5 (https=)
JP2016508505A5 (https=)
JP2018519323A5 (https=)
JP2010517990A5 (https=)
JP2009534406A5 (https=)
JP2007507542A5 (https=)
JP2010536766A5 (https=)
JP2011509261A5 (https=)
JP2010530897A5 (https=)
JP2010526814A5 (https=)
JP2011526244A5 (https=)
JP2011522056A5 (https=)
JP2007508359A5 (https=)
JP2009500347A5 (https=)
WO2008096870A1 (ja) アザ架橋環化合物